Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adriamycin, vincristine and mitomycin C as first and second line therapy for advanced breast carcinoma

Published:1988-06 Issue:2 Volume:5 Page:125-128
ISSN:0736-0118
Container-title:Medical Oncology and Tumor Pharmacotherapy
language:en
Short-container-title:Med. Oncol. & Tumor Pharmacother.

Author:

Harding M.,Sangster G.,Milsted R. A. V.,Kaye S. B.,Calman K. C.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/BF02985450.pdf

Reference10 articles.

1. Tormey D C, Gelman R, Band P Ret al.: Comparison of induction chemotherapies for metastatic breast cancer.Cancer 50, 1235 (1982).

2. Steiner R, Stewart J F, Cantwell B M Jet al.: Adriamycin alone or combined with vincristine in the treatment of advanced breast cancer.Eur J Cancer clin Oncol 19, 1553 (1983).

3. Tormey D C: Adriamycin (NSC — 123127) in breast cancer: an overview of studies.Cancer Chemother Rep 6, 319 (1975).

4. Friedman M A, Marcus F S, Cassidy M Jet al.: 5-fluorouracil + oncovin + adriamycin + mitomycin C (FOAM): an effective program for breast cancer, even for disease refractory to previous chemotherapy.Cancer 52, 192 (1983).

5. Shipp S K, Muss H B, Westrick M Aet al.: Vincristine, doxorubicin and mitomycin (VAM) in patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate and fluorouracil (CMF).Cancer Chemother Pharmac 11, 130 (1983).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP